Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancerPLANTING, A. S. T; STOTER, G; VERWEIJ, J et al.European journal of cancer. Part A. 1993, Vol 29, Num 4, pp 518-519Article

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neckPLANTING, A. S. T; DE MULDER, P. H. M; DE GRAEFF, A et al.European journal of cancer (1990). 1997, Vol 33, Num 1, pp 61-65, issn 0959-8049Article

Phase II study on oral N-methylformamide in metastatic colorectal cancerPLANTING, A. S. T; KLIJN, J. G. M; VERWEIJ, J et al.Cancer treatment reports. 1987, Vol 71, Num 12, pp 1293-1294, issn 0361-5960Article

5-fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknow primaryVAN DER GAAST, A; VERWEIJ, J; PLANTING, A. S. T et al.European journal of cancer & clinical oncology. 1988, Vol 24, Num 4, pp 765-768, issn 0277-5379Article

Preoperative chemoradiation with capecitabine in locally advanced rectal cancerDE BRUIN, A. F. J; NUYTTENS, J. J; FERENSCHILD, F. T. J et al.Netherlands journal of medicine. 2008, Vol 66, Num 2, issn 0300-2977, 71-76 [6 p.]Article

A comparison of clinical pharmacodynamics of different administration schedules of oral topotecan (hycamtin)GERRITS, C. J. H; SCHELLENS, J. H. M; VON HOFF, D. D et al.Clinical cancer research. 1999, Vol 5, Num 1, pp 69-75, issn 1078-0432Article

Five days of oral topotecan (Hycamtin®), a phase I and pharmacological study in adult patients with solid tumoursGERRITS, C. J. H; BURRIS, H; VERWEIJ, J et al.European journal of cancer (1990). 1998, Vol 34, Num 7, pp 1030-1035, issn 0959-8049Article

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumorsPRONK, L. C; SCHELLENS, J. H. M; BRUNO, R et al.Journal of clinical oncology. 1997, Vol 15, Num 3, pp 1071-1079, issn 0732-183XArticle

Phase I and pharmacologic study of oral Topotecan administered twice daily for 21 days to adult patients with solid tumorsCREEMERS, G. J; GERRITS, C. J. H; VERWEIJ, J et al.Journal of clinical oncology. 1997, Vol 15, Num 3, pp 1087-1093, issn 0732-183XArticle

Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09SCHELLENS, J. H. M; PLANTING, A. S. T; VAN ACKER, B. A. C et al.Journal of the National Cancer Institute. 1994, Vol 86, Num 12, pp 906-912, issn 0027-8874Article

Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumoursPLANTING, A. S. T; VAN DER BURG, M. E. L; DE BOER-DENNERT, M et al.British journal of cancer. 1993, Vol 68, Num 4, pp 789-792, issn 0007-0920Article

Abnormal liver metabolism in cancer patients detected by ³¹P MR spectroscopyDAGNELIE, P. C; SIJENS, P. E; KRAUS, D. J. A et al.NMR in biomedicine. 1999, Vol 12, Num 8, pp 535-544, issn 0952-3480Article

Analysis of cumulative probabilities shows that the efficacy of 5HT₃ antagonist prophylaxis is not maintainedDE WIT, R; SCHMITZ, P. I. M; VERWEIJ, J et al.Journal of clinical oncology. 1996, Vol 14, Num 2, pp 644-651, issn 0732-183XArticle

Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancerCREEMERS, G. J; GERRITS, C. J. H; STOTER, G et al.Journal of clinical oncology. 1996, Vol 14, Num 9, pp 2540-2545, issn 0732-183XArticle

Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancerVAN DER GAAST, A; BONTENBAL, M; PLANTING, A. S. T et al.Annals of oncology. 1994, Vol 5, Num 9, pp 858-860, issn 0923-7534Article

Weekly high-dose cisplatin in malignant pleural mesotheliomaPLANTING, A. S. T; SCHELLENS, J. H. M; GOEY, S. H et al.Annals of oncology. 1994, Vol 5, Num 4, pp 373-374, issn 0923-7534Article

Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancerBONTENBAL, M; PLANTING, A. S. T; RODENBURG, C. J et al.Breast cancer research and treatment. 1992, Vol 21, Num 2, pp 133-138, issn 0167-6806Article

Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II studyPOSTMUS, P. E; SPLINTER, T. A. W; VAN ZANDWIJK, N et al.European journal of cancer (1990). 1992, Vol 28, Num 1, pp 96-100, issn 0959-8049Conference Paper

Docetaxel and cisplatin : An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck: Results of a phase II study of the EORTC Early Clinical Studies GroupSCHÖFFSKI, P; CATIMEL, G; PLANTING, A. S. T et al.Annals of oncology. 1999, Vol 10, Num 1, pp 119-122, issn 0923-7534Article

Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumorsDE JONGE, M. J. A; PUNT, C. J. A; WAGENER, D. J. T et al.Journal of clinical oncology. 1999, Vol 17, Num 7, pp 2219-2226, issn 0732-183XArticle

The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitorGERRITS, C. J. H; SCHELLENS, J. H. M; CREEMERS, G. J et al.British journal of cancer. 1997, Vol 76, Num 7, pp 946-951, issn 0007-0920Article

Etoposide in malignant pleural mesothelioma : Two phase II trials of the EORTC Lung Cancer Cooperative GroupSAHMOUD, T; POSTMUS, P. E; BAAS, P et al.European journal of cancer (1990). 1997, Vol 33, Num 13, pp 2211-2215, issn 0959-8049Article

Local tumor control in radiation therapy of cancers in the head and neckLEVENDAG, P. C; NOWAK, P. J. C. M; VAN DER SANGEN, M. J. C et al.American journal of clinical oncology. 1996, Vol 19, Num 5, pp 469-477, issn 0277-3732Article

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumoursSCHELLENS, J. H. M; MA, J; PLANTING, A. S. T et al.British journal of cancer. 1996, Vol 73, Num 12, pp 1569-1575, issn 0007-0920Article

Phase I study of intravenous fosquidone (GR63178A-NSC D611615) using a three times a week schedulePLANTING, A. S. T; VAN DER BURG, M. E. L; STOTER, G et al.Clinical oncology. 1992, Vol 4, Num 3, pp 171-173Article